Differential Use of Available Genetic Tests among Primary Care Physicians in the U.S.: Results of a National Survey

Harvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities, Massachusetts General Hospital/Partners HealthCare, Boston, Massachusetts, USA.
Genetics in medicine: official journal of the American College of Medical Genetics (Impact Factor: 7.33). 07/2008; 10(6):404-14. DOI: 10.1097/GIM.0b013e3181770184
Source: PubMed


This study assesses primary care physicians' experience ordering and referring patients for genetic testing, and whether minority-serving physicians are less likely than those serving fewer minorities to offer such services.
Survey of a random sample of 2000 primary care physicians in the United States (n = 1120, 62.3% response rate based on eligible respondents) conducted in 2002 to assess what proportion have (1) ever ordered a genetic test in general or for select conditions; (2) ever referred a patient for genetic testing to a genetics center or counselor, a specialist, a clinical research trial, or to any site of care.
Nationally, 60% of primary care physicians have ordered a genetic test and 74% have referred a patient for genetic testing. Approximately 62% of physicians have referred a patient for genetic testing to a genetics center/counselor or to a specialist, and 17% to a clinical trial. Minority-serving physicians were significantly less likely to have ever ordered a genetic test for breast cancer, colorectal cancer, or Huntington disease, or to have ever referred a patient for genetic testing relative to those serving fewer minorities.
Reduced utilization of genetic tests/referrals among minority-serving physicians emphasizes the importance of tracking the diffusion of genomic medicine and assessing the potential impact on health disparities.

Download full-text


Available from: Douglas E Levy, Jul 25, 2014
  • Source
    • "Despite this, several surveys performed in the U.S., Europe and Canada show that doctors are not prepared for the increasing use of genetics in clinical care (Acton et al., 2000; Batra et al., 2002; Bellcross et al., 2011; Bethea et al., 2008; Burke et al., 2009; Carroll et al., 2008; Escher and Sappino, 2000; Freedman et al., 2003; Klitzman et al., 2012; Mehnert et al., 2003; Nippert et al., 2011; Pichert et al., 2003; Sabatino et al., 2007; Shields et al., 2008; Sifri et al., 2003; Toiviainen and Hemminki, 2001; Trivers et al., 2011; Van Riel et al., 2010; Welkenhuysen and Evers-Kiebooms, 2002; White et al., 2008; Wideroff et al., 2003; Wideroff et al., 2005; Wilkins-Haug et al., 2000). Many physicians do not have any specific education and the vast majority does not feel they have the needed training and knowledge for the appropriate use of genetic testing to guide prevention or treatment decisions (Anon, 2011; Feero and Green, 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genetic testing for cancer susceptibility is an emerging technology in medicine. This study assessed the knowledge, attitudes and professional behavior of Italian physicians regarding the use of predictive genetic tests for breast and colorectal cancer, including the BRCA1/2 and APC tests. A cross-sectional survey of a random sample of Italian physicians was performed in 2010 through a self-administered questionnaire. A response rate of 69.6% (1,079 questionnaires) was achieved. A significant lack of knowledge was detected, particularly for APC testing. Less than half of the physicians agreed on the importance of efficacy and cost-effectiveness evidence in the selection of predictive genetic tests to be offered to the patients. Multiple logistic regression analyses showed that education had a positive influence on knowledge, attitudes and, to a lesser extent, professional use. The factor most strongly related to the physicians' use of genetic testing was patients requests for breast (OR=12.65; 95% CI 7.77-20.59) or colorectal cancer tests (OR=7.02; 95% CI 3.61-13.64). A high level of interest for specific training was reported by almost all physicians surveyed. Targeted educational programs are needed to improve the expertise of physicians, and, ultimately, to enhance the appropriate use of genetic tests in clinical practice.
    Preventive Medicine 07/2013; 57(5). DOI:10.1016/j.ypmed.2013.06.022 · 3.09 Impact Factor
  • Source
    • "An earlier American study showed major differences in genetic services offered to consanguineous couples by clinical geneticists and genetic counselors [13]. Moreover, the total number of genetic counseling consultations for people from migrant populations is generally low [14,15]. It is suggested that lack of genetic knowledge as well as racialized and stereotypical perspectives of health care professionals are contributing to these low numbers [16]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background It is often suggested that an effort must be made to increase awareness among consanguineous couples of their reproductive risk, and to refer them for genetic counseling if needed. Primary care professionals are considered most appropriate for addressing the subject and identifying couples at risk during consultations in their practice. This Dutch study aims to explore the experiences, attitudes and beliefs of such professionals regarding their care for consanguineous couples. Methods Sixteen semi-structured interviews were conducted with midwives and general practitioners. Results Although most primary care professionals considered it their task to inform couples about the risks of consanguinity, during consultations the topic was generally only briefly touched upon and quickly abandoned. Important reasons for this were professionals’ beliefs about religious and social values of couples, their low perception of the couples’ reproductive risk and expected limited feasibility of referral. Feelings of embarrassment regarding addressing consanguinity did not seem to play a significant role. Conclusions Primary care professional beliefs about their clients’ religious and social values, their attitudes toward the risk, and perceived limited options for referral seem to conflict with the professional norm to address the topic of consanguinity.
    BMC Family Practice 10/2012; 13(1):105. DOI:10.1186/1471-2296-13-105 · 1.67 Impact Factor
  • Source
    • "However, the preponderance of research evidence demonstrates that alcohol dependence is a multifactorial disease resulting from genes and environment (Cloninger et al., 1981; Schuckit, 1981; Pickens et al., 1991; McGue et al., 1992; Prescott and Kendler, 1999). Emerging genetic medicine research on other multifactorial diseases such as diabetes, cardiovascular disease, and cancer has provided a greater need for health care professionals to provide genetic services (Hotlzman, 1993; Shields et al., 2008). More importantly, the patient who is knowledgeable about genetic concepts is better equipped to make informed decisions about genetic testing, medical treatment, and continuity of care. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to investigate the association between HLA DR/DQ and inflammatory bowel diseases (IBD) in Tunisian patients and to determine the relationship between HLA DR/DQ alleles with the clinical disease patterns. DNA typing of human leukocyte antigen (HLA) genes was performed in 70 ulcerative colitis (UC) patients, 40 Crohn's disease (CD) patients, and 123 healthy controls (HC) using a polymerase chain reaction sequence specific primer technique. Data were analyzed using Cochran-Mantel-Haenszel test and binary logistic regression. Compared with HC, IBD patients showed an increased frequency of the homozygous DRB1*07 genotype. This positive association was maintained when UC and CD were separately compared to HC. In UC patients, DQB1*03:02 was predictive of colonic extension whereas DRB1*13 and DQB1*03:01 were associated limited disease localization (left-sided colitis and proctitis). The DRB1*15 allele increased in patients with extraintestinal manifestations. In CD, female patients showed an increased frequency of DRB1*13, DRB1*15, and DQB1*06 alleles and DRB1*13-DQB1*06 haplotype, whereas a significant increase of DRB1*07, DQB1*02 alleles, and DRB1*07-DQB1*02 haplotype was noted in male patients. These results show a significant association of the homozygous HLA-DRB1*07 genotype with UC and CD and of several HLA DR/DQ alleles and haplotypes with the clinical phenotypes of these diseases in Tunisian patients. Because of limited statistical power, our study findings are subject to further investigation.
    Genetic Testing and Molecular Biomarkers 01/2012; 16(6):482-7. DOI:10.1089/gtmb.2011.0132 · 1.46 Impact Factor
Show more